Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 10 € there is potential for a 614.29% increase which would mean more than doubling the current price of 1.4 € for Cocrystal Pharma Inc..
Our community identified positive and negative aspects for Cocrystal Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cocrystal Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cocrystal Pharma Inc. | - | 1.449% | 7.692% | -38.596% | -9.677% | -88.333% | - |
Gritstone Oncology Inc | 13.680% | 16.156% | -19.102% | -60.022% | -52.018% | -88.090% | - |
Avid Bioservices Inc | 0.700% | 5.109% | 24.138% | -55.556% | 18.033% | -60.000% | 78.174% |
Pacira Pharmaceuticals | 3.310% | 4.167% | -3.101% | -39.614% | -16.107% | -50.000% | -41.038% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $12.00 to $10.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat